TABLE 3.
The functions of specific lncRNAs for each cancer.
Group | Cancer | ID | Function | FDR q-value |
---|---|---|---|---|
down | BLCA | GO:0,036,297 | interstrand cross-link repair | 3.34E-03 |
up | BLCA | GO:0,010,729 | positive regulation of hydrogen peroxide biosynthetic process | 2.77E-05 |
down | BRCA | GO:0,048,284 | organelle fusion | 6.43E-03 |
up | BRCA | GO:0,040,030 | regulation of molecular function, epigenetic | 1.15E-10 |
down | CESC | GO:0,001,887 | selenium compound metabolic process | 2.47E-04 |
up | CESC | GO:0,048,846 | axon extension involved in axon guidance | 4.69E-03 |
down | CHOL | GO:0,034,587 | piRNA metabolic process | 1.32E-02 |
up | CHOL | GO:0,045,008 | Depyrimidination | 1.29E-12 |
down | COAD | GO:0,018,016 | N-terminal peptidyl-proline dimethylation | 4.41E-13 |
up | COAD | GO:0,034,214 | protein hexamerization | 1.23E-05 |
up | ESCA | GO:0,010,157 | response to chlorate | 4.36E-08 |
up | GBM | GO:2,001,162 | positive regulation of histone H3-K79 methylation | 7.71E-03 |
down | HNSC | GO:0,030,157 | pancreatic juice secretion | 2.35E-02 |
up | HNSC | GO:0,005,993 | trehalose catabolic process | 3.32E-03 |
down | KIRC | GO:0,046,597 | negative regulation of viral entry into host cell | 3.49E-18 |
down | KIRP | GO:0,007,144 | female meiosis I | 8.51E-03 |
up | KIRP | GO:0,046,878 | positive regulation of saliva secretion | 1.03E-02 |
down | LIHC | GO:0,045,008 | Depyrimidination | 2.81E-13 |
up | LIHC | GO:0,021,897 | forebrain astrocyte development | 1.48E-05 |
up | LUAD | GO:0,035,814 | negative regulation of renal sodium excretion | 3.03E-03 |
down | LUSC | GO:0,019,358 | nicotinate nucleotide salvage | 1.34E-03 |
up | LUSC | GO:0,045,006 | DNA deamination | 1.65E-02 |
down | PAAD | GO:0,070,585 | protein localization to mitochondrion | 1.63E-08 |
up | PAAD | GO:0,046,329 | negative regulation of JNK cascade | 1.04E-05 |
down | PCPG | GO:0,021,723 | medullary reticular formation development | 3.25E-05 |
up | PCPG | GO:0,006,335 | DNA replication-dependent nucleosome assembly | 1.72E-04 |
down | PRAD | GO:0,001,957 | intramembranous ossification | 5.15E-03 |
up | PRAD | GO:0,045,053 | protein retention in Golgi apparatus | 6.23E-09 |
down | READ | GO:0,060,123 | regulation of growth hormone secretion | 6.57E-05 |
up | READ | GO:0,042,742 | defense response to bacterium | 3.49E-04 |
down | SARC | GO:0,010,324 | membrane invagination | 7.69E-05 |
up | SKCM | GO:0,002,931 | response to ischemia | 8.74E-05 |
down | STAD | GO:0,080,184 | response to phenylpropanoid | 1.85E-04 |
down | THCA | GO:0,007,161 | calcium-independent cell-matrix adhesion | 8.69E-05 |
down | UCEC | GO:2,000,978 | negative regulation of forebrain neuron differentiation | 1.50E-03 |
up | UCEC | GO:0,070,208 | protein heterotrimerization | 1.10E-07 |